CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amsel Medical Corporation and Mayo Clinic today announced the signing of a Patent License Agreement for certain intellectual property developed by Mayo Clinic inventors (Henna Kalsi, M.D., a Mayo Clinic cardiologist, Thom W. Rooke, M.D., a Mayo Clinic cardiologist, Alex Streeter, Mayo Clinic Engineering, Raymond Phelps, Mayo Clinic Engineering, and James H. Christensen, Mayo Clinic Engineering). Amsel Medical intends to incorporate the licensed intellectual property in the development of the Amsel Occluder Device. The Amsel Occluder Device is intended for use on tubular structures or blood vessels wherever a metal ligating clip is indicated and within the size range of 2.0mm to 7.0mm diameter.
On May 20th, 2014, Amsel Medical Corporation announced that it had successfully completed filing of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Amsel Occluder Device1.
Arnold Miller, MD, Founder and President of Amsel Medical Corporation commented, “We are thrilled to collaborate with the Mayo Clinic as we continue the development of the Amsel Occluder Device. A fundamental part of our strategy rests upon assembling broad-based intellectual property protections for our development efforts. The signing of this Patent License Agreement is a key component of that strategy. Following our recent announcement of the Pre-Marketing Notification (510(k)) with FDA for the Amsel Occluder, we anticipate significant clinical interest for this innovative technology in the markets where the Amsel Occluder will be cleared for commercial distribution.”
About the Amsel Occluder Device
The Amsel Occluder Device is designed to easily and securely close blood vessels (veins or arteries as well as hollow ducts) during surgical procedures. The Amsel Occluder Device is intended for use on tubular structures or blood vessels wherever a metal ligating clip is indicated, and within the size range of 2.0mm to 7.0mm diameter. The Amsel Occluder Device employs a proprietary mechanical design that enables a vessel clamp to be introduced during open surgery. The Amsel Occluder Device transfixes the target vessel with the clamp to provide closure.
About the Mayo Clinic and the Mayo Foundation For Medical Education And Research
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit mayoclinic.org, http://www.mayoclinic.org/ and newsnetwork.mayoclinic.org.
About Amsel Medical Corporation
Amsel Medical Corporation, a development stage medical device company, founded in 2011, is developing the Amsel Occluder Device which is intended for simple and secure vessel or duct closure. The company has operations in Cambridge, MA, and Tel Aviv, Israel. The Amsel Occluder Device addresses an estimated 31 million2,3 annual US surgical procedures where vessel closure is required.
1 Patents pending
2 CDC/NCHS National Hospital Discharge Survey, 2010
3 Company Estimates
